NDRS approach to understanding rare disease and cancer at a population level.

TOPICS COVERED

Presentations by leading specialists in the field of Histiocytosis to include:

  • Haemophagocytic Lymphohistiocytosis (HLH) Langerhans Cell Histiocytosis (LCH)
  • Juvenile xanthogranuloma (JXG)
  • Rosai-Dorfman Disease (RD)
  • Erdheim-Chester disease (ECD)
  • Abstract Presentations

Call for Abstracts OPEN Please contact Histio@HistioUK.org for Guidelines.
https://app.oxfordabstracts.com/stages/2984/submitter

WHO SHOULD ATTEND?

  • Clinicians
  • Consultants
  • Trainees and Researchers
  • GP's Patients
  • Parents of Histiocytic disorders.

Those interested in development and knowledge transfer of theses rare disorders.

SPEAKERS

  • Dr. Eli Diamond - Member of the interdisciplinary team at Memorial Sloan Kettering treating and studying patients with histiocytic disorders such as Erdheim-Chester disease and Langerhans cell histiocytosis. Clinical Expertise - Neuro-Oncology; Adult Brain Tumours; Histiocytosis.
  • Dr. Rebecca Marsh – Member of the paediatric haematologist-oncologist team affiliated with Cincinnati Children's Hospital Medical Center.
  • Dr Mark Bishton - Consultant Haematologist, Nottinghamshire University Hospitals Trust:
  • Hanhua Liu - Senior Cancer Intelligence Analyst, Public Health England;
  • Peter Stilwell - Senior Data Analyst, Public Health England.

Representatives of the HiHASC HLH Across Speciality Collaboration.
Hosted by: Prof. M. Collin and Dr. C. Booth

For more information, please contact: Histio@HistioUK.org

  • 12:00 - 18/11/2021 to 16:30 - 18/11/2021
  • United Kingdom